Safety, pharmacokinetics, and pharmacodynamics of BMS-986142, a novel reversible BTK inhibitor, in healthy participants

Những quyển sách tương tự

• Safety, pharmacokinetics and pharmacodynamics of branebrutinib (BMS‐986195), a covalent, irreversible inhibitor of Bruton's tyrosine kinase: Randomised phase I, placebo‐controlled trial in healthy participants
  Bằng: Catlett, Ian M., et al.
  Được phát hành: (2020)
• First‐in‐human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS‐962212, a direct, reversible, small molecule factor XIa inhibitor in non‐Japanese and Japanese healthy subjects
  Bằng: Perera, Vidya, et al.
  Được phát hành: (2018)
• Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
  Bằng: Holze, Friederike, et al.
  Được phát hành: (2020)
• Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat
  Bằng: Giraudel, Jerome M, et al.
  Được phát hành: (2005)
• Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide
  Bằng: Clearie, Karine L, et al.
  Được phát hành: (2011)